​製薬マネー論文

Response to "Strictness and Transparency in Approval Process of Medical Products: Japanese Situation"

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto

Toyoaki Sawano

Clinical Pharmacology & Therapeutics

15

Overview and Transparency of Non-research Payments to Healthcare Organizations and Healthcare Professionals from Pharmaceutical Companies in Japan: Analysis of Payment Data in 2016

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Akihiko Ozaki, Hiroaki Saito, Yuki Senoo, Toyoaki Sawano, Yuki Shimada, Yurie Kobashi, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

Akihiko Ozaki

Health Policy

14

Pharmaceutical company payments to Japanese government drug regulation committee members

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Sawano T, Ozaki A, Saito H, Shimada Y, Tanimoto T

Toyoaki Sawano

Clinical Pharmacology & Therapeutics

13

Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

Hiroaki Saito

Journal of Bone and Joint Surgery

12

Japan's drug regulation framework: aiming for better health or bigger profits

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Akihiko Ozaki, Yuki Senoo, Hiroaki Saito, Andy Crump, Tetsuya Tanimoto

Akihiko Ozaki

International Journal of Health Policy and Management

11

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Yurie Kobashi, Makoto Watanabe, Hideaki Kimura, Asaka Higuchi, Akihiko Ozaki

Yurie Kobashi

International Journal of Health Policy and Management

10

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Akihiko Ozaki, Hiroaki Saito, Yosuke Onoue, Toyoaki Sawano, Yuki Shimada, Yurie Somekawa, Aritsune Tsuji, Tetsuya Tanimoto

Akihiko Ozaki

BMJ Open

9

Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Hiroaki Saito, Yuta Tani, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Tetsuya Tanimoto

Hiroaki Saito

Clinical Microbiology and Infection

8

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto

Toyoaki Sawano

JAMA Network Open

7

Transparency of clinical evidence for medical devices in Europe

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Tetsuya Tanimoto, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Akihiko Ozaki

Tetsuya Tanimoto

Lancet

6

Evaluation of pharmaceutical company payments and conflict of interest disclosures among oncology clinical practice guideline authors in Japan

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Tetsuya Tanimoto

Hiroaki Saito

JAMA Network Open

5

Pharmaceutical company payments to executive board members of professional medical associations in Japan

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Hiroaki Saito, Akihiko Ozaki, Yasuma Kobayashi, Toyoaki Sawano, Tetsuya Tanimoto

Hiroaki Saito

JAMA Internal Medicine

4

Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto

Yuki Shimada

Alzheimer's & Dementia: Translational Research & Clinical Interventions

3

A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of medicine

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Akihiko Ozaki, Morihito Takita, Tetsuya Tanimoto

Akihiko Ozaki

Investigational New Drugs

2

Conflict of interest and the CREATE-X trial in the New England Journal of medicine

Authors:

No.

Date:

First Author:

Journal/Book:

URL:

Title:

Akihiko Ozaki

Akihiko Ozaki

Science and Engineering Ethics

1